Biomaterial Database

[Metabolites of anti-arrhythmia agents, their pharmacodynamics and pharmacokinetics]. 1990

Adnan Abdalla, and N A Mazur, and N V Shestakova

UI	MeSH Term	Description	Entries
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.	Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic

Related Publications

Adnan Abdalla, and N A Mazur, and N V Shestakova

[Relation between pharmacodynamics and the pharmacokinetics of anti-arrhythmia agents].

January 1982, Farmakologiia i toksikologiia,

Adnan Abdalla, and N A Mazur, and N V Shestakova

[Pharmacodynamics and pharmacokinetics of loracainide, a new anti-arrhythmia agent].

January 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,

Adnan Abdalla, and N A Mazur, and N V Shestakova

Stereoselective pharmacokinetics and pharmacodynamics of anti-asthma agents.

April 2002, The Annals of pharmacotherapy,

Adnan Abdalla, and N A Mazur, and N V Shestakova

[Pharmacokinetics of the principal anti-arrhythmia agents].

January 1978, Coeur et medecine interne,

Adnan Abdalla, and N A Mazur, and N V Shestakova

[Classification of anti-arrhythmia agents and their characteristics].

July 1991, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,

Adnan Abdalla, and N A Mazur, and N V Shestakova

[Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents].

April 1992, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,

Adnan Abdalla, and N A Mazur, and N V Shestakova

Pharmacokinetics and pharmacodynamics of cardiovascular agents.

January 1999, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia,

Adnan Abdalla, and N A Mazur, and N V Shestakova

Pharmacokinetics and pharmacodynamics of antibacterial agents.

December 2009, Infectious disease clinics of North America,

Adnan Abdalla, and N A Mazur, and N V Shestakova

[Anti-arrhythmia agents and their effects on atrioventricular conduction].

January 1982, Nihon rinsho. Japanese journal of clinical medicine,

Adnan Abdalla, and N A Mazur, and N V Shestakova

Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

May 2004, Antimicrobial agents and chemotherapy,